SCHEMBL284371

SCHEMBL284371

O=C(O)CNCC(=O)O.[NaH]

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.47
EGLN1 Q9GZT9 3/20 0.47
LDHA P00338 1/20 0.47
SRR Q9GZT4 1/20 0.47
ALKBH5 Q6P6C2 1/20 0.47
SUCNR1 Q9BXA5 1/20 0.47
SLC22A6 Q4U2R8 1/20 0.41
CTH P32929 1/20 0.39
TSHR P16473 2/20 0.39
NFKB1 P19838 1/20 0.39
PMP22 Q01453 1/20 0.39
KDM4E B2RXH2 2/20 0.38
KDM5C P41229 2/20 0.38
PHF8 Q9UPP1 2/20 0.38
KDM2A Q9Y2K7 2/20 0.38
KDM6B O15054 1/20 0.38
FOLH1 Q04609 1/20 0.38
FFAR3 O14843 2/20 0.37
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL667660 1.00 LMNA (0.47) LMNAEGLN1LDHASRRALKBH5
SCHEMBL29262203 0.96 LMNA (0.44) LMNAEGLN1LDHASRRALKBH5
Water SCHEMBL10705898 0.96 LMNA (0.44) LMNAEGLN1LDHASRRALKBH5
Water SCHEMBL27594738 0.96 LMNA (0.44) LMNAEGLN1LDHASRRALKBH5
SCHEMBL27023 0.96
SCHEMBL4816014 0.96 LMNA (0.50) LMNAEGLN1LDHASRRALKBH5
SCHEMBL735923 0.93
SCHEMBL3464176 0.92 LMNA (0.47) LMNAEGLN1LDHASRRALKBH5
Ammonia Solution, Strong SCHEMBL7262621 0.92 LMNA (0.47) LMNAEGLN1LDHASRRALKBH5
SCHEMBL9393647 0.92 LMNA (0.47) LMNAEGLN1LDHASRRALKBH5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 279 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119263329-B Preparation method of barium hydroxide octahydrate 山东辰安化学有限公司 2025-05-09 CN claimed
US-20250091013-A1 Three-Compartment Bipolar Membrane Electrodialysis Of Salts Of Amino Acids MONSANTO TECHNOLOGY LLC 2025-03-20 US claimed
CN-119499861-A Synergistic accelerator suitable for SNCR denitration and application thereof 华东理工大学 2025-02-25 CN claimed
CN-119409264-A Method for removing antimony by using zirconium functionalized adsorption resin 杨凌核盛辐照技术有限公司 2025-02-11 CN claimed
CN-119263329-A Preparation method of barium hydroxide octahydrate 山东辰安化学有限公司 2025-01-07 CN claimed
US-12186709-B2 Three-compartment bipolar membrane electrodialysis of salts of amino acids MONSANTO TECHNOLOGY LLC (US) 2025-01-07 US claimed
CN-119020787-A Etching solution and application of etching solution in etching more than two layers of metal films 上海盛剑微电子有限公司 2024-11-26 CN claimed
CN-117976951-B Negative electrode electrolyte of all-iron water-based flow battery 北京化工大学 2024-09-13 CN claimed
CN-118406387-A Preparation method of methyl xylenol blue 河北百灵威超精细材料有限公司 2024-07-30 CN claimed
CN-118106014-A Preparation method and application of catalyst for methane and carbon dioxide combined reforming 万华化学集团股份有限公司 2024-05-31 CN claimed
EP-2009442-A2 Aggregation and dispersion methods of magnetic particles, separation and detection methods using the same and detection kit Chisso Corporation (JP) 2008-12-31 EP claimed
CN-101186581-A Continuous clean synthesis method for sodium iminodiacetate FUWEI YANG (CN) 2008-05-28 CN claimed
CN-1743306-A Imido diacetate environment-protection clean production method ANQING SHUGUANG CHEMICAL GROUP (CN) 2006-03-08 CN claimed
JP-2001508043-A 2001-06-19 JP claimed
US-5986128-A ACIDIFICATION AND PHOSPHONATION MONSANTO COMPANY (US) 1999-11-16 US claimed
EP-0935595-A1 USE OF MONOSODIUM IMINODIACETIC ACID SOLUTIONS IN THE PREPARATION OF N-PHOSPHONOMETHYLIMINODIACETIC ACID MONSANTO COMPANY (US) 1999-08-18 EP claimed
WO-1998019992-A1 USE OF MONOSODIUM IMINODIACETIC ACID SOLUTIONS IN THE PREPARATION OF N-PHOSPHONOMETHYLIMINODIACETIC ACID MONSANTO COMPANY (US) 1998-05-14 WO claimed
EP-0180673-B1 MIXTURES CONTAINING NITRILOTRIACETIC ACID AND IMINODIACETIC ACID (OR SALTS THEREOF) AS A SEQUESTERING AGENT THE DOW CHEMICAL COMPANY (US) 1988-09-14 EP claimed
EP-0180673-A1 Mixtures containing nitrilotriacetic acid and iminodiacetic acid (or salts thereof) as a sequestering agent THE DOW CHEMICAL COMPANY (US) 1986-05-14 EP claimed
US-4486339-A CHELATION OF CALCIUM AND MAGNESIUM, DETERGENT FORMULATIONS THE DOW CHEMICAL COMPANY (US) 1984-12-04 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12186709-B2 Three-compartment bipolar membrane electrodialysis of salts of amino acids SLC1A3, SLC1A2, SLC1A1 LMNA 2289/4885EGLN1 4206/4885LDHA 2100/4885
US-20250091013-A1 Three-Compartment Bipolar Membrane Electrodialysis Of Salts Of Amino Acids SLC1A3, SLC1A2, SLC1A1 LMNA 2289/4885EGLN1 4206/4885LDHA 2100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.